Found a bug or want a feature? Verified reports earn free credits.
Log inSign up
Back to alerts
CONCORDBIONSEConcord Biotech Limited· Pharmaceuticals & BiotechnologyHighPositive
Announced Fri, 8 Aug, 2025 · 16:56 IST

Concord Biotech Limited has informed the Exchange that Record date for the purpose of Dividend is 03-Sep-2025.

Corporate Actions View source PDFExplain this filing

CONCORDBIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.6%Reaction day
₹1595.00
prior close
₹1486.10
announcement price
After-mkt
timing
Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.5%+0.2% vs market
Pharmaceuticals peers, median of 148sector+0.3%+0.3% vs sector

On the reaction day the stock moved 0.2 pts more than Nifty Smallcap 250 and 0.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.9
10m
+1.6
15m
+1.6
30m
+3.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.6+0.5+0.2+0.3+0.3
Next day
+3.3+0.5+2.8+0.3+3.0
2d
+2.6+1.1+1.5+0.6+2.0
3d
+2.2+0.7+1.5-0.3+2.6
4d
+2.5+2.0+0.5+0.4+2.1
5d
+3.0+2.8+0.1+0.6+2.4
1w
+9.7+3.2+6.5+0.6+9.1
15d
+6.3+2.6+3.6+0.1+6.2
1m
+3.1+3.3-0.2+1.3+1.8
2m
-1.4+3.2-4.6-1.6+0.2
3m
-9.0+2.7-11.8-4.2-4.9
UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 148Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Concord Biotech's board has approved the unaudited standalone and consolidated financial results for Q1 FY26 (ended June 30, 2025), reviewed by the audit committee and with an unmodified opinion from statutory auditors BSR & Co. LLP. The board has fixed Wednesday, September 3, 2025 as the record date to identify shareholders entitled to receive the dividend. The dividend is Rs. 10.70 per equity share on a face value of Re. 1, declared for FY 2024-25. The board meeting was held on August 8, 2025, from 3:00 PM to 4:00 PM.

Likely market impact

Investors who hold Concord Biotech shares as of the September 3, 2025 record date will be eligible to receive the Rs. 10.70 per share dividend, signalling a healthy payout from the company for FY25.